Predictive value of baseline levels and early dynamic changes of ctDNA for 28-day mortality in ICU patients with advanced lung cancer: a prospective single-center cohort study.

Authors

Liping Tan, Dongxi Lu, Haijiao Huang, Dongyi Lin, Dingwen Zheng

Published in

Frontiers in molecular biosciences. Volume 13. Pages 1811387. Epub Jun 23, 2026.

Abstract

Critically ill patients with advanced lung cancer admitted to the ICU have high short-term mortality and heterogeneous outcomes. Conventional severity measures reflect organ failure but not tumor-related activity.
To assess whether baseline ctDNA and 72-h ctDNA dynamics are associated with 28-day mortality and whether they add incremental prognostic value beyond clinical variables.
In this prospective single-center cohort, 293 patients formed the full cohort; a 72 ± 6-h landmark dynamic cohort included 233 patients alive and evaluable at 72 h. Plasma ctDNA was tested at ICU admission and 72 h. Multivariable logistic regression and restricted cubic splines assessed associations. Model discrimination, calibration metrics, reclassification, and decision curve net benefit were compared before and after adding ctDNA.
Baseline ctDNA was higher in non-survivors than survivors (P < 0.001). Baseline ctDNA [ln(VAFmax_T0+0.05)] was independently associated with 28-day mortality and showed a nonlinear relationship (Poverall<0.001, Pnonlinear = 0.028). In the landmark cohort, ΔctDNA was independently associated with mortality from 72 h to day 28 (adjusted ORs 1.86 and 1.62; both P < 0.01). Adding ctDNA improved performance: AUC increased from 0.78 to 0.84 and Brier score decreased from 0.201 to 0.184 in the full cohort; AUC increased from 0.75 to 0.80 and Brier score decreased from 0.219 to 0.207 in the dynamic cohort. NRI/IDI were 0.42/0.08 and 0.29/0.05, respectively.
Baseline ctDNA and early ctDNA dynamics were independently associated with short-term mortality and modestly improved prognostic model performance. These findings suggest potential value for ICU risk stratification pending external validation.

PMID:
42416486
Bibliographic data and abstract were imported from PubMed on 08 Jul 2026.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.